Charles Brigden
Algemeen Directeur bij Eliptica Ltd.
Profiel
Mr. Charles Brigden is Senior Vice President & Head-Business Development at BTG Plc.
He received his MBA from Columbia Business School.
Actieve functies van Charles Brigden
Bedrijven | Functie | Begin |
---|---|---|
Eliptica Ltd.
Eliptica Ltd. Miscellaneous Commercial ServicesCommercial Services Eliptica Ltd. is a British company that specializes in research and experimental development on biotechnology. The private company was founded in 2022 by Markus Ralser, Aleksej Zelezniak, Charles Brigden. Charles Brigden has been the CEO since 2022. | Algemeen Directeur | 01-04-2022 |
Eerdere bekende functies van Charles Brigden
Bedrijven | Functie | Einde |
---|---|---|
BTG | Corporate Officer/Principal | - |
Opleiding van Charles Brigden
Columbia Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
BTG Ltd.
BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
Eliptica Ltd.
Eliptica Ltd. Miscellaneous Commercial ServicesCommercial Services Eliptica Ltd. is a British company that specializes in research and experimental development on biotechnology. The private company was founded in 2022 by Markus Ralser, Aleksej Zelezniak, Charles Brigden. Charles Brigden has been the CEO since 2022. | Commercial Services |